In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism

By the ESC WG on Pulmonary Circulation & RVF

Clinical

This study, based on the Pulmonary Embolism Response Team (PERT) Consortium Registry, aimed to understand the management and outcomes of patients with high-risk pulmonary embolism (PE). It found that high-risk PE patients were more often treated with advanced therapies compared to intermediate-risk patients. Patients with haemodynamic instability experienced high rates of in-hospital mortality and major bleeding. Factors such as vasopressor use, extracorporeal membrane oxygenation, identified clot-in-transit, and malignancy were linked to increased in-hospital mortality. Particularly, catastrophic PE patients showed even higher mortality rates. This comprehensive analysis highlights the severe impact and treatment challenges of high-risk PE.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.

Contact us

ESC Working Group on Pulmonary Circulation & Right Ventricular Function

European Society of Cardiology

European Heart House
Les Templiers
2035 Route des Colles
CS 80179 Biot

06903, Sophia Antipolis, FR

Tel: +33.4.92.94.76.00